Fuji Pharma Co., Ltd. (4554.T) JPX

Currency In JPY

AD

Valuation

Market Cap45.56B
Enterprise Value57.38B
P/E Ratio16.83
PEG Ratio-1.63
Price/Sales Ratio0.78
Price/Book Ratio0.92
Enterprise/Revenue0.97
Enterprise/EBITDA6.37

Fiscal Year

Fiscal YearSeptember 30, 2026
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.05
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue62.39B
Revenue/Share2,411.33
Gross Profit22.77B
EBITDA6.36B
Net Income2.83B
Diluted EPS111.18

Balance Sheet

Total Cash9.5B
Total Cash/Share367.04
Total Debt21.32B
Total Debt/Equity0.41
Current Ratio1.65
Book Value Per Share2,027.4

Price History

52-Week Change18.91
52-Week High2,559
52-Week Low1,572
Moving Average 50 Days1,809.4
Moving Average 200 Days2,059.84

Statistics

Average Volume114,803
Shares Outstanding26.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate52
Trailing Annual Dividend Yield2.8
Payout Ratio0.37
Last Split Factor2:1
Last Split DateJune 27, 2018
AD